Pharmacokinetic/pharmacodynamic evaluation of levonorgestrel butanoate for female contraception
Ended Awarded Last action
- Contract number
- 75N94018F00008
- Awardee
-
Oregon Health & Science University UEI NPSNT86JKN51
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $632,381
Award facts
- Contract value 100% obligated
- $632,381.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Portland, OR 97239, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $9,472 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $33,674 | |
| Funding Only Action | $25,793 | |
| Funding Only Action | $97,624 | |
| Funding Only Action | $97,519 | |
| Funding Only Action | $160,207 | |
| Original award | $208,092 |
About this award
The National Institute of Child Health and Human Development (NICHD) awarded a delivery order contract valued at $632,381.06 to Oregon Health & Science University (OHSU) on September 25, 2018, with an ultimate completion date of July 14, 2026. This cost-no-fee delivery order supports research and development activities to evaluate the pharmacokinetics, pharmacodynamic effects, cycle control, and safety of levonorgestrel butanoate (LB), a long-acting injectable formulation being developed for female contraception. The study specifically compares outcomes in both obese and non-obese women, with work to be performed at OHSU's location in Portland, Oregon. No set-aside designation was applied to this award, indicating competitive selection in the federal contracting process.
OHSU, a prominent academic medical center and state-controlled institution based in Portland, Oregon, brings substantial expertise in contraceptive efficacy research to this engagement. The institution has established itself as a critical research partner to NICHD, having previously contracted for central laboratory services supporting contraceptive efficacy studies and holding multiple grants from the institute for contraceptive development and evaluation. This delivery order leverages OHSU's extensive capabilities in specialized medical research, biostatistical support, and clinical research services to advance the development of this novel long-acting contraceptive option.
Quick answers
Who was awarded contract 75N94018F00008?
75N94018F00008 was awarded to Oregon Health & Science University by National Institute of Child Health and Human Development (National Institutes of Health) on September 25, 2018.
How much is contract 75N94018F00008 worth?
The government has obligated $632,381 on 75N94018F00008.
Is contract 75N94018F00008 an order under another contract?
Yes. 75N94018F00008 is a delivery order under HHSN275201300008I, an indefinite delivery contract.
Was contract 75N94018F00008 competed?
The extent of competition for 75N94018F00008 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award